Grupo 1: Oncología Interdisciplinar y Biotecnológica
Código de grupo: 6.01
Tipo de grupo: Consolidado
Descripción del grupo: Oncología interdisciplinar y biotecnológica
Jefe de Grupo: Dra. Ana Álvarez González y Dra. Mercedes Muñoz Fernández
Integrantes del grupo | |
---|---|
Investigadores y personal de apoyo |
ALONSO | FARTO | JUAN CARLOS | Recognised Researcher |
ÁLVAREZ | GONZÁLEZ | ANA | |
AYALA | LÁZARO | RAFAEL | First Stage Researcher |
CALÍN | LORCA | ANA | |
CALVO | MANUEL | FELIPE ÁNGEL | |
CASCON | PEREZ-TEIJON | MARIA ELENA | |
CUERVO | DEHESA | MIGUEL | |
DEL VALLE | HERNÁNDEZ | EMILIO | |
GARCÍA | HERNÁNDEZ | MARÍA JESÚS | |
GARCÍA | LEAL | ROBERTO | |
GÓMEZ | CORES | SUSANA | |
GONZÁLEZ | SAN SEGUNDO | CARMEN | |
LEAMAN | ALCIBAR | OLWEN ERIETE | |
LÓPEZ | LÓPEZ | ANA MARÍA | |
LOZANO | BARRIUSO | MIGUEL ANGEL | |
MEDIAVILLA | SANTOS | LYDIA | Recognised Researcher |
MORENO | DOMENE | MERCEDES | |
MUÑOZ | FERNANDEZ | MERCEDES | |
NAVARRO | CUELLAR | CARLOS | Recognised Researcher |
NAVARRO | CUELLAR | IGNACIO | |
OCHANDIANO | CAICOYA | SANTIAGO | |
ORCAJO | RINCÓN | JAVIER | |
ORTIZ | QUINTANA | LUIS | |
PELIGROS | GÓMEZ | MARÍA ISABEL | |
PRIETO | RODRIGUEZ | MARIA JESUS | |
RAMON | BOTELLA | ENRIQUE | |
RODRÍGUEZ | MARTÍN | MARCOS | |
ROTGER | REGÍ | AMANDA | |
RUIZ | GALAN | GEMA | |
SALMERON | ESCOBAR | JOSE IGNACIO | Recognised Researcher |
SANCHEZ | LUIS | SILVIA | |
SANTOS | RODRIGUEZ | MARINA | |
SIERRA | DÍAZ | FERNANDO | |
TAVERA | POMATA | PATRICIA | |
TOUSIDONIS | RIAL | MANUEL ALEJANDRO |
Líneas de Investigación | |||
---|---|---|---|
Axis 1: High-precision radiotherapy (intraoperative radiotherapy)
L1: Stereotactic surgical navigation. L2: In vivo dosimetry guided by 3D printing. L3: Mobile miniature linear accelerator: pre-robotization and automation. Axis 2: Biological response in oncology L1: Post-radiochemotherapy response. L2: Biological dosimetry: chromosomal liquid biopsy. L3: Post-neoadjuvant radioresistance and radiosensitivity. L4: Oncologic bioimaging and response. Axis 3: Oligocancer L1: Radiosurgical rescue. L2: Staging by functional imaging. L3: Proton therapy: clinical models. |
First decile publications | 5 | 147,8 |
First quartile publications | 9 | 167,0 |
Second quartile publications | 10 | 38,2 |
Third quartile publications | 3 | 8,4 |
Total publications (including those without IF) | 38 | 223,0 |